| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |